middle.news
Neurotech Accelerates Pediatric Cannabinoid Therapy with European Partner
9:58am on Thursday 13th of February, 2025 AEDT
•
Biotechnology
Read Story
Neurotech Accelerates Pediatric Cannabinoid Therapy with European Partner
9:58am on Thursday 13th of February, 2025 AEDT
Key Points
Partnership with RH Farma, subsidiary of European Cannabis Company
Development of strain-agnostic, broad-spectrum cannabinoid drug for pediatric neurological conditions
Initial upfront payment of €25,000 with a 12-month development term
Focus on regulatory compliance and GMP standards for global market readiness
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Neurotech International (ASX:NTI)
OPEN ARTICLE